OBI Pharma shareholders’ meeting launches new company strategy and embraces transformation 

Strong emphasis on developing ADC assets and technology platform and encouraging global collaborations and partnership   OBI PHARMA, INC. (4174 TWO ) has undergone meaningful transformation over the past year. From pipeline refresh, organizational restructuring, to cultural revitalization, the company’s commitment to innovation is evident. Dr. Heidi Wang, CEO of OBI, emphasizes that this transformation […]